Molybdenum Citrate Encyclopedia — Scientific Background

What Is Molybdenum Citrate?

Molybdenum citrate (CAS 74873-24-8) is the molybdenum salt of citric acid, chemically characterized by the molecular formula C₂₄H₂₀Mo₃O₂₈ and a molecular weight of approximately 1044.2 g/mol. It is a chelated form of molybdenum that has been recognized in the FDA Global Substance Registration System with the unique ingredient identifier (UNII) BQ2CRB3TW9 and is listed in the WHO Drug Dictionary as a defined substance. The compound is a white to off-white crystalline powder that is soluble in water, yielding a nearly clear to pale yellow solution when dissolved.

The Molybdenum Cofactor (Moco)

Molybdenum is a transition element that is essential for microorganisms, plants, and animals. To gain biological activity in the cell, molybdenum must be complexed by a pterin scaffold to form the molybdenum cofactor (Moco). Moco is the active compound at the catalytic site of all molybdenum-containing enzymes, which catalyze key reactions in global carbon, sulfur, and nitrogen metabolism. In humans, four molybdoenzymes are known: sulfite oxidase, xanthine oxidoreductase, aldehyde oxidase, and mitochondrial amidoxime reducing component (mARC).

Mechanisms of Action

Sulfite Oxidase — Sulfur Metabolism and Detoxification

Sulfite oxidase is a molybdoenzyme that catalyzes the oxidation of sulfite to sulfate, the final step in the metabolism of sulfur-containing amino acids (cysteine and methionine). This enzyme is critical for detoxifying sulfite, which is otherwise toxic to cells. Molybdenum is a cofactor in the enzyme sulfite oxidase, which detoxifies sulfite to harmless sulfate for excretion, and molybdenum supplementation is recommended for individuals with sulfite sensitivity. Sulfite oxidase deficiency in humans results in severe neurological damage and typically leads to early childhood death.

Xanthine Oxidoreductase — Purine Metabolism

Xanthine oxidoreductase (also known as xanthine dehydrogenase/oxidase) is a molybdoenzyme that catalyzes the oxidation of hypoxanthine to xanthine and xanthine to uric acid in purine metabolism. This enzyme is essential for the breakdown of purines from DNA and RNA and is targeted by allopurinol in the treatment of gout and hyperuricemia.

Aldehyde Oxidase — Drug and Xenobiotic Metabolism

Aldehyde oxidase is a molybdoenzyme involved in the metabolism of aldehydes and various xenobiotics, including drugs. Molybdenum helps break down drugs and toxic substances that enter the body through this enzyme system.

Mitochondrial Amidoxime Reducing Component (mARC)

The mitochondrial amidoxime reducing component (mARC) is the fourth human molybdoenzyme, which is involved in the reduction of N-hydroxylated compounds and plays a role in cellular detoxification and nitrogen metabolism.

Physiological Functions of Molybdenum

Sulfur Amino Acid Metabolism

Molybdenum is required for the metabolism of sulfur-containing amino acids, including cysteine and methionine. Without adequate molybdenum, the body cannot properly metabolize these sulfur amino acids, leading to the accumulation of toxic sulfite.

DNA and RNA Metabolism

Molybdenum is involved in the metabolism of nitrogen-containing compounds found in DNA and RNA, including purine nucleotides.

Iron Utilization and Copper Metabolism

Molybdenum plays a role in iron utilization and the metabolism of copper. Studies have shown that high levels of dietary molybdenum, up to 1,500 mcg, can cause excessive excretion of copper. Absorption of molybdenum affects the absorption of iron, copper, and sulfate by competing for the same intestinal brush-border receptor sites.

Detoxification Pathways

Molybdenum is essential for the detoxification of sulfites, aldehydes, and various xenobiotics. The molybdoenzyme systems play critical roles in both phase I and phase II detoxification pathways. Molybdenum is a component of several important metalloenzymes that participate in liver detoxification pathways.

The Bioavailability Challenge

Molybdenum absorption is influenced by several factors. The amount absorbed decreases with increasing doses and is lower when molybdenum is ingested with a meal. Oral absorption can range between 40 and 100% depending on these factors.

While molybdenum is generally well absorbed, the chelated citrate form may offer advantages in terms of solubility and absorption compared to inorganic molybdenum salts, allowing for more efficient uptake and utilization by the body. Molybdenum citrate 1% is a specialized chemical compound designed for advanced applications, comprising 1% molybdenum in a citrate form that offers enhanced solubility and bioavailability.

liposomal encapsulation addresses potential limitations through a phospholipid bilayer that protects the molybdenum-citrate complex during digestive transit, enhances intestinal absorption through lipid-mediated pathways, and provides sustained release for prolonged enzymatic support.

Clinical Evidence

Molybdenum Cofactor Deficiency

Molybdenum cofactor deficiency is a rare genetic disorder that prevents the body from using molybdenum. It can cause seizures and severe brain damage that usually leads to death within days after birth. This condition highlights the critical importance of molybdenum for human health and survival.

Sulfite Sensitivity

Molybdenum supplementation is recommended for individuals with sulfite sensitivity due to its role as a cofactor in sulfite oxidase, which detoxifies sulfite to harmless sulfate for excretion. Sulfite sensitivity can manifest as respiratory symptoms, skin reactions, or gastrointestinal discomfort in susceptible individuals.

Dental Caries Prevention

Epidemiological evidence indicates that molybdenum is a trace mineral associated with decreased incidence of dental caries.

Cancer Prevention

Epidemiological studies show that there is a 30 percent increased rate of esophageal cancer in areas of the United States where there is low or no molybdenum in the drinking water, and in areas where food is grown on molybdenum-poor soil.

Molybdenum Deficiency

Molybdenum deficiency is very rare in healthy people. It occurs in individuals with a very rare genetic disorder called molybdenum cofactor deficiency, which prevents the body from using molybdenum. Molybdenum deficiency has been occasionally determined in individuals who have been receiving prolonged total parenteral nutrition. Due to rapid excretion rates in the urine, molybdenum toxicity is low in humans.

Safety and Regulatory

Molybdenum from food and beverages does not cause harm. However, people exposed to high levels of molybdenum in the air and soil, such as miners and metalworkers, sometimes develop achy joints, gout-like symptoms, and high blood levels of uric acid.

Molybdenum is likely safe when used in amounts that do not exceed the Tolerable Upper Intake Level (UL) of 2 mg daily. It is generally well-tolerated. However, it is possibly unsafe when used in amounts greater than 2 mg daily. Excess intake of molybdenum (10–15 mg/day) can cause a gout-like syndrome due to an elevated production of uric acid. Very high levels of molybdenum in the diet have been linked with gout.

For pregnancy and breastfeeding, molybdenum is likely safe when used in amounts that do not exceed the UL of 1.7 mg daily for those 14 to 18 years, or 2 mg daily for those 19 and older. It is possibly unsafe when used in higher doses.

Molybdenum is primarily excreted in the urine, with lesser amounts excreted in feces. Because of rapid excretion, molybdenum toxicity is low in humans.

Molybdenum citrate is widely commercialized as a dietary supplement ingredient. In the United States, molybdenum supplements are available as multivitamin/mineral supplements and as standalone products. Food-grade molybdenum citrate is available with certifications including ISO9001, ISO22000, KOSHER, and HALAL, and is GMO-free, vegan/vegetarian friendly, and allergen-safe. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

139$/KG